Cargando…

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

Sodium-glucose co-transporter 2 (SGLT2) inhibitors block glucose reabsorption in the renal proximal tubule, an insulin-independent mechanism that plays a critical role in glycemic regulation in diabetes. In addition to their glucose-lowering effects, SGLT2 inhibitors prevent both renal damage and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvatore, Teresa, Galiero, Raffaele, Caturano, Alfredo, Rinaldi, Luca, Di Martino, Anna, Albanese, Gaetana, Di Salvo, Jessica, Epifani, Raffaella, Marfella, Raffaele, Docimo, Giovanni, Lettieri, Miriam, Sardu, Celestino, Sasso, Ferdinando Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998569/ https://www.ncbi.nlm.nih.gov/pubmed/35409011 http://dx.doi.org/10.3390/ijms23073651

Ejemplares similares

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021)

Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
por: Salvatore, Teresa, et al.
Publicado: (2021)

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
por: Salvatore, Teresa, et al.
Publicado: (2022)

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2022)

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021)

Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
por: Nevola, Riccardo, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023)

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
por: Salvatore, Teresa, et al.
Publicado: (2020)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia
por: Galiero, Raffaele, et al.
Publicado: (2022)

HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
por: Sardu, Celestino, et al.
Publicado: (2021)

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2021)

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
por: Caturano, Alfredo, et al.
Publicado: (2023)

Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020)

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2019)

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
por: Rinaldi, Luca, et al.
Publicado: (2021)

Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study
por: Galiero, Raffaele, et al.
Publicado: (2022)

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
por: Cuomo, Giovanna, et al.
Publicado: (2023)

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy
por: Galiero, Raffaele, et al.
Publicado: (2020)

SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis
por: Sardu, Celestino, et al.
Publicado: (2023)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
por: Caturano, Alfredo, et al.
Publicado: (2019)

Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes
por: Marfella, Raffaele, et al.
Publicado: (2023)

Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023)

Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
por: Sardu, Celestino, et al.
Publicado: (2020)

Evidence for human diabetic cardiomyopathy
por: Marfella, Raffaele, et al.
Publicado: (2021)

Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern Italy
por: Sardu, Celestino, et al.
Publicado: (2020)

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
por: Galiero, Raffaele, et al.
Publicado: (2020)

Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

COVID-19 and Its Cardiovascular Effects: Risk Factors, Prevention and Management
por: Sardu, Celestino, et al.
Publicado: (2023)

Class effects of SGLT2 inhibitors on cardiorenal outcomes
por: Kluger, Aaron Y., et al.
Publicado: (2019)

Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
por: Hou, Yi-Chou, et al.
Publicado: (2020)

Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
por: Sardu, Celestino, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rgpsui6ptjci2oifio8nnc9hrm